Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification

Tian Tian, Jiajun Li, Yizhuo Li, Yun‐Xin Lu, Yan‐Lai Tang, Hua Wang, Fufu Zheng, Dingbo Shi, Long Qian, Miao Chen,

Theranostics · 2019 · 35 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

: This study indicates that melatonin, alone or in combination with sorafenib, has potential to improve the therapeutic outcome of AML patients with FLT3-ITD mutation that merits further investigation.

References

29